Viewing nowLiragenta Tablet 5 mg (Linagliptin Besilate)
Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

MFDS item code 202400690 · Approved 2024.03.29 · Insurance code 665003300
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used alongside diet and exercise to help control blood sugar in patients with type 2 diabetes. It can be used alone or in combination with other medications to further enhance blood sugar control. This helps in managing blood sugar levels stably and preventing complications associated with diabetes. Thus, it is effectively used for blood sugar control in patients with type 2 diabetes.
The recommended dose of this medicine is 5 mg of linagliptin once daily (6.67 mg linagliptin benzoate). It may be administered with or without food. When used in combination with insulin or an insulin secretagogue (e.g., a sulfonylurea), a lower dose of insulin and the insulin secretagogue may be needed to minimize the risk of hypoglycemia.
This medication should not be used in patients with allergies to the active ingredient or other components. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis. When used in combination with insulin or sulfonylureas, there may be an increased risk of hypoglycemia, so dosage adjustments may be necessary. Caution is required when using this medication in patients with mild to moderate heart failure, and it is not recommended for patients with severe heart failure. Acute pancreatitis symptoms may occur during treatment with this medication; thus, if severe abdominal pain arises, discontinue use immediately and consult a physician. Furthermore, a blistering condition similar to dermatitis herpetiformis may occur, and if such symptoms appear, discontinue use immediately and consult a specialist. There may be symptoms of hypoglycemia during treatment, so attention should be paid to symptoms and appropriate measures taken if necessary. The safety of this medication has not been established for pregnant or breastfeeding women; therefore, its use is not recommended, especially with breastfeeding requiring caution. Use in children under 10 years is not recommended, and for adolescents over 10 years, safety and efficacy have not been sufficiently confirmed. Elderly patients or those with impaired kidney and liver function can use this medication without special dosage adjustments. In case of overdose, remove unabsorbed medication from the gastrointestinal tract and observe symptoms while receiving necessary treatment. This medication should be kept out of reach of children, and it is crucial to avoid transferring it to another container to maintain safety and quality.
Hypoglycemia, nasopharyngitis, hypersensitivity, angioedema, urticaria, hypertriglyceridemia, hyperlipidemia, cough, pancreatitis, constipation, oral ulcer, rash, similar pemphigus, severe and disability-associated arthralgia, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, epigastric pain, enterocolitis, intestinal obstruction, gastritis, herpes zoster, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, decreased appetite, cerebral infarction, speech disorder, Alzheimer's dementia, chest pain, fever, facial edema, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, liver metastasis, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, stomach cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage renal disease, acute cholangitis, acute cholecystitis, cholangitis, dizziness, kidney transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, dizziness, sensory impairment, chest discomfort, weakness, pain, nosebleed, oropharyngeal pain, speech disorders, allergic rhinitis, exercise-induced dyspnea, wet cough, runny nose, lung mass, arthralgia, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, muscle pain, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased blood triglycerides, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, elevated serum potassium, increased serum creatinine, increased serum creatine phosphokinase, elevated ALT, androgenic alopecia, diabetic foot disease, hyperhidrosis, hair loss, dermatitis, anxiety, affective disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, lacerations, palpitations, dry eye, glaucoma, cataract, eye discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, cholelithiasis, hearing loss, erectile dysfunction, thyroid goiter, pruritus, hypertension, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly closed container. A storage temperature of 1 to 30 degrees Celsius at room temperature is recommended. This helps maintain the efficacy and safety of the medication over time.
Pink round film-coated tablet
30 tablets/bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowLinagliptin Besylate 6.67mg
Tablet · Prescription medication
Kyungbo Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Linagliptin Besylate 6.67mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.